- Home
- AMRN vs WIA Comparison
AMRN vs WIA Comparison
Compare AMRN & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- WIA
- Stock Information
- Founded
- AMRN 1989
- WIA 2003
- Country
- AMRN Ireland
- WIA United States
- Employees
- AMRN N/A
- WIA N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- AMRN Health Care
- WIA Finance
- Exchange
- AMRN Nasdaq
- WIA Nasdaq
- Market Cap
- AMRN 216.0M
- WIA 192.9M
- IPO Year
- AMRN 1993
- WIA N/A
- Fundamental
- Price
- AMRN $16.90
- WIA $8.37
- Analyst Decision
- AMRN Strong Sell
- WIA
- Analyst Count
- AMRN 1
- WIA 0
- Target Price
- AMRN $12.00
- WIA N/A
- AVG Volume (30 Days)
- AMRN 171.7K
- WIA 39.2K
- Earning Date
- AMRN 07-30-2025
- WIA 01-01-0001
- Dividend Yield
- AMRN N/A
- WIA 12.29%
- EPS Growth
- AMRN N/A
- WIA N/A
- EPS
- AMRN N/A
- WIA N/A
- Revenue
- AMRN $214,112,000.00
- WIA N/A
- Revenue This Year
- AMRN N/A
- WIA N/A
- Revenue Next Year
- AMRN N/A
- WIA N/A
- P/E Ratio
- AMRN N/A
- WIA N/A
- Revenue Growth
- AMRN N/A
- WIA N/A
- 52 Week Low
- AMRN $7.08
- WIA $7.56
- 52 Week High
- AMRN $17.49
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- AMRN 71.53
- WIA 60.11
- Support Level
- AMRN $16.12
- WIA $8.25
- Resistance Level
- AMRN $17.49
- WIA $8.44
- Average True Range (ATR)
- AMRN 0.96
- WIA 0.06
- MACD
- AMRN 0.05
- WIA -0.00
- Stochastic Oscillator
- AMRN 90.37
- WIA 57.14
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.